Flavopereirine Suppresses the Progression of Human Oral Cancer by Inhibiting the JAK-STAT Signaling Pathway via Targeting LASP1

References

• HusseinAA, HelderMN, de VisscherJG, et al. Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: a systematic review. Eur j Cancer. 2017;82:115–127. doi:10.1016/j.ejca.2017.05.02628654785
   PubMed Web of Science ®Google Scholar
• KumarM, NanavatiR, ModiTG, DobariyaC. Oral cancer: etiology and risk factors: a review. J Cancer Res Ther. 2016;12(2):458–463. doi:10.4103/0973-1482.18669627461593
   PubMed Web of Science ®Google Scholar
• GeumDH, RohYC, YoonSY, et al. The impact factors on 5-year survival rate in patients operated with oral cancer. J Korean Assoc Oral Maxillofacial Surg. 2013;39(5):207–216. doi:10.5125/jkaoms.2013.39.5.207
   Google Scholar
• GlennyAM, FurnessS, WorthingtonHV, et al. Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy. Cochrane Database Syst Rev. 2010;(12):Cd006387.21154367
   PubMed Web of Science ®Google Scholar
• da SilvaESJV, Cordovil BrigidoHP, Oliveira de AlbuquerqueKC, et al. Flavopereirine-an alkaloid derived from geissospermum vellosii-presents leishmanicidal activity in vitro. Molecules (Basel, Switzerland). 2019;24:4.
   Web of Science ®Google Scholar
• LiJM, HuangYC. Flavopereirine suppresses the growth of colorectal cancer cells through P53 signaling dependence. Cancers. 2019;11:7.
   Web of Science ®Google Scholar
• YehHT, TsaiYS, ChenMS, et al. Flavopereirine induces cell cycle arrest and apoptosis via the AKT/p38 MAPK/ERK1/2 signaling pathway in human breast cancer cells. Eur J Pharmacol. 2019;863:172658. doi:10.1016/j.ejphar.2019.17265831518562
   PubMed Web of Science ®Google Scholar
• BeljanskiM, CrochetS, BeljanskiMS. PB-100: a potent and selective inhibitor of human BCNU resistant glioblastoma cell multiplication. Anticancer Res. 1993;13(6a):2301–2308.8297150
   PubMed Web of Science ®Google Scholar
• BeljanskiM, CrochetS. The selective anticancer agent pb-100 inhibits interleukin-6 induced enhancement of glioblastoma cell-proliferation in-vitro. Int J Oncol. 1994;5(4):873–879. doi:10.3892/ijo.5.4.87321559655
   PubMed Web of Science ®Google Scholar
• BeljanskiM, CrochetS. The selective anticancer agents PB-100 and BG-8 are active against human melanoma cells, but do not affect non malignant fibroblasts. Int J Oncol. 1996;8(6):1143–1148. doi:10.3892/ijo.8.6.114321544475
   PubMed Web of Science ®Google Scholar
• SamsonovA, ZenserN, ZhangF, ZhangH, FetterJ, MalkovD. Tagging of genomic STAT3 and STAT1 with fluorescent proteins and insertion of a luciferase reporter in the cyclin D1 gene provides a modified A549 cell line to screen for selective STAT3 inhibitors. PLoS One. 2013;8(7):e68391. doi:10.1371/journal.pone.006839123950841
   PubMed Web of Science ®Google Scholar
• XuF, LiQ, WangZ, CaoX. Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a. Biomed Pharmacother. 2019;112:108592. doi:10.1016/j.biopha.2019.01.05330784907
   PubMed Web of Science ®Google Scholar
• PatelMR, DashA. JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models. Nov. 2019;26(11–12):411–418.
   Google Scholar
• TanJ, XiangL, XuG. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma. Jul. 2019;71(7):882–890.
   Google Scholar
• SubramaniamA, ShanmugamMK, PerumalE, et al. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. Biochim Biophys Acta. 2013;1835(1):46–60.23103770
   PubMed Web of Science ®Google Scholar
• GurbuzV, KonacE, VarolN, et al. Effects of AG490 and S3I-201 on regulation of the JAK/STAT3 signaling pathway in relation to angiogenesis in TRAIL-resistant prostate cancer cells in vitro. Oncol Lett. 2014;7(3):755–763. doi:10.3892/ol.2014.179524520293
   PubMed Web of Science ®Google Scholar
• ZhangJ, SunZ, SunP, ChenT, ChenF. Microalgal carotenoids: beneficial effects and potential in human health. Food Funct. 2014;5(3):413–425. doi:10.1039/c3fo60607d24480814
   PubMed Web of Science ®Google Scholar
• KowshikJ, BabaAB, GiriH, Deepak ReddyG, DixitM, NaginiS. Astaxanthin inhibits JAK/STAT-3 signaling to abrogate cell proliferation, invasion and angiogenesis in a hamster model of oral cancer. PLoS One. 2014;9(10):e109114. doi:10.1371/journal.pone.010911425296162
   PubMed Web of Science ®Google Scholar
• RuanP, TaoZ, TanA. Low expression of miR-30a-5p induced the proliferation and invasion of oral cancer via promoting the expression of FAP. Biosci Rep. 2018;38:1. doi:10.1042/BSR20171027
   Web of Science ®Google Scholar
• WenQ, LuoK, HuangH, LiaoW, YangH. Xanthoxyletin inhibits proliferation of human oral squamous carcinoma cells and induces apoptosis, autophagy, and cell cycle arrest by modulation of the MEK/ERK signaling pathway. Med Sci Monitor. 2019;25:8025–8033. doi:10.12659/MSM.911697
   Web of Science ®Google Scholar
• FoschiniMP, GaibaA, CocchiR, et al. Pattern of p63 expression in squamous cell carcinoma of the oral cavity. Virchows Archiv. 2004;444(4):332–339. doi:10.1007/s00428-003-0969-x14997391
   PubMed Web of Science ®Google Scholar
• KakkarV, VermaMK, SainiK, KaurIP. Nano drug delivery in treatment of oral cancer, a review of the literature. Curr Drug Targets. 2019;20(10):1008–1017. doi:10.2174/138945012066619031912573430892161
   PubMed Web of Science ®Google Scholar
• DuffD, LongA. Roles for RACK1 in cancer cell migration and invasion. Cell Signal. 2017;35:250–255. doi:10.1016/j.cellsig.2017.03.00528336233
   PubMed Web of Science ®Google Scholar
• VossAK, StrasserA. The essentials of developmental apoptosis. F1000Research. 2020;9:148. doi:10.12688/f1000research.21571.1
   Google Scholar
• ShintaniT, RosliSNZ, TakatsuF, et al. Eldecalcitol (ED-71), an analog of 1α,25-dihydroxyvitamin D3 as a potential anti-cancer agent for oral squamous cell carcinomas. J Steroid Biochem Mol Biol. 2016;164:79–84. doi:10.1016/j.jsbmb.2015.09.04326444325
   PubMed Web of Science ®Google Scholar
• ChoJH, JeonYJ, ParkSM, et al. Multifunctional effects of honokiol as an anti-inflammatory and anti-cancer drug in human oral squamous cancer cells and xenograft. Biomaterials. 2015;53:274–284. doi:10.1016/j.biomaterials.2015.02.09125890726
   PubMed Web of Science ®Google Scholar
• LeeHM, PatelV, ShyurLF, LeeWL. Copper supplementation amplifies the anti-tumor effect of curcumin in oral cancer cells. Phytomedicine. 2016;23(12):1535–1544. doi:10.1016/j.phymed.2016.09.00527765374
   PubMed Web of Science ®Google Scholar
• YangIH, JungJY, KimSH, et al. ABT-263 exhibits apoptosis-inducing potential in oral cancer cells by targeting C/EBP-homologous protein. Jun. 2019;42(3):357–368.
   Google Scholar
• HaradaK, FerdousT, UeyamaY. Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer. Japanese Dental Sci Rev. 2017;53(3):61–77. doi:10.1016/j.jdsr.2016.11.001
   Web of Science ®Google Scholar
• TomasettoC, Moog-LutzC, RégnierCH, SchreiberV, BassetP, RioMC. Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domains. FEBS Lett. 1995;373(3):245–249. doi:10.1016/0014-5793(95)01040-L7589475
   PubMed Web of Science ®Google Scholar
• OrthMF, CazesA, ButtE, GrunewaldTG. An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein. Oncotarget. 2015;6(1):26–42. doi:10.18632/oncotarget.308325622104
   PubMedGoogle Scholar
• GrunewaldTG, KammererU, WinklerC, et al. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. Br J Cancer. 2007;96(2):296–305. doi:10.1038/sj.bjc.660354517211471
   PubMed Web of Science ®Google Scholar
• ZhaoL, WangH, LiuC, et al. Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1. Gut. 2010;59(9):1226–1235. doi:10.1136/gut.2009.20273920660701
   PubMed Web of Science ®Google Scholar
• ChiyomaruT, EnokidaH, KawakamiK, et al. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urol Oncol. 2012;30(4):434–443. doi:10.1016/j.urolonc.2010.05.00820843712
   PubMed Web of Science ®Google Scholar
• ShimizuF, ShiibaM, OgawaraK, et al. Overexpression of LIM and SH3 Protein 1 leading to accelerated G2/M phase transition contributes to enhanced tumourigenesis in oral cancer. PLoS One. 2013;8(12):e83187. doi:10.1371/journal.pone.008318724386158
   PubMed Web of Science ®Google Scholar
• XiaoH, BidHK, JouD, et al. A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells. J Biol Chem. 2015;290(6):3418–3429. doi:10.1074/jbc.M114.61674825313399
   PubMed Web of Science ®Google Scholar
• HuangJS, YaoCJ, ChuangSE, et al. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction. BMC Cancer. 2016;16:245. doi:10.1186/s12885-016-2265-627012679
   PubMed Web of Science ®Google Scholar
• PouyfungP, ChoonateS, WongnoppavichA, RongnoparutP, ChairatvitK. Anti-proliferative effect of 8α-tigloyloxyhirsutinolide-13-O-acetate (8αTGH) isolated from Vernonia cinerea on oral squamous cell carcinoma through inhibition of STAT3 and STAT2 phosphorylation. Phytomedicine. 2019;52:238–246. doi:10.1016/j.phymed.2018.09.21130599904
   PubMed Web of Science ®Google Scholar
• BabaAB, NivethaR, ChattopadhyayI, NaginiS. Blueberry and malvidin inhibit cell cycle progression and induce mitochondrial-mediated apoptosis by abrogating the JAK/STAT-3 signalling pathway. Food Chem Toxicol. 2017;109(Pt 1):534–543. doi:10.1016/j.fct.2017.09.05428974439
   PubMed Web of Science ®Google Scholar
• IshimotoT, KatoY. Physiolgically-based pharmacokinetics: theory and examples. Clin Calcium. 2016;26(11):1529–1537.27777386
   PubMedGoogle Scholar